Chemoradiotherapy With or Without Atezolizumab in Treating Patients With Localized Muscle Invasive Bladder Cancer

Clinical trial NCT03775265 · ACTIVE_NOT_RECRUITING

Trial details

NCT number: NCT03775265
Sponsor: National Cancer Institute (NCI)
Status: ACTIVE_NOT_RECRUITING
Phase: Phase 3
Study type: INTERVENTIONAL

Bladder Urothelial Carcinoma Muscle Invasive Bladder Carcinoma Stage II Bladder Cancer AJCC v8 Stage IIIA Bladder Cancer AJCC v8

Start date: 2019-06-03
Primary completion: 2027-06-01
Enrollment: 475

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.